LEPU MED.T.B. SP.GDR O.N. - Asset Resilience Ratio
LEPU MED.T.B. SP.GDR O.N. (07Z0) has an Asset Resilience Ratio of 1.37% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See LEPU MED.T.B. SP.GDR O.N. short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how LEPU MED.T.B. SP.GDR O.N.'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 07Z0 current and non-current assets.
Liquid Assets Composition Over Time
This chart breaks down LEPU MED.T.B. SP.GDR O.N.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read debt load of LEPU MED.T.B. SP.GDR O.N. for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €350.77 Million | 1.37% |
| Total Liquid Assets | €350.77 Million | 1.37% |
Asset Resilience Insights
- Limited Liquidity: LEPU MED.T.B. SP.GDR O.N. maintains only 1.37% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
LEPU MED.T.B. SP.GDR O.N. Industry Peers by Asset Resilience Ratio
Compare LEPU MED.T.B. SP.GDR O.N.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
COPLAND ROAD CAPITAL NEW
F:A2P |
Medical Devices | 0.00% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Shanghai Kinetic Medical Co
SHE:300326 |
Medical Devices | 28.89% |
Annual Asset Resilience Ratio for LEPU MED.T.B. SP.GDR O.N. (2022–2025)
The table below shows the annual Asset Resilience Ratio data for LEPU MED.T.B. SP.GDR O.N..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.78% | €203.31 Million ≈ $237.69 Million |
€26.14 Billion ≈ $30.56 Billion |
-0.34pp |
| 2024-12-31 | 1.12% | €274.86 Million ≈ $321.34 Million |
€24.57 Billion ≈ $28.73 Billion |
+0.02pp |
| 2023-12-31 | 1.10% | €275.20 Million ≈ $321.74 Million |
€25.02 Billion ≈ $29.25 Billion |
-0.03pp |
| 2022-12-31 | 1.13% | €277.21 Million ≈ $324.09 Million |
€24.48 Billion ≈ $28.63 Billion |
-- |
About LEPU MED.T.B. SP.GDR O.N.
Lepu Medical Technology (Beijing) Co., Ltd., together with its subsidiaries, engages in the research, development, and manufacturing of cardiac interventional medical devices in China and internationally. The company operates through three segments: Medical Devices; Pharmaceuticals; and Medical Services and Health Management. It offers medical devices, including cardiovascular devices, in vitro d… Read more